Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,148
datasets available to search
ShareScore release 0.9.0
Dataset results
2,148 results for “HER2”
Safety and QoL of Trastuzumab With Lapatinib or Chemiotherapy in MBC and HER2+ Patients Refractory to Anti HER2 Therapies
ClinicalTrials.gov study NCT02238509. IPD Sharing: NO. Countries: 1. Publications: 15.
Electroacupuncture Combined With Paclitaxel Protein-bound and PD-1 Antibody for Second-line Treatment of HER2 Negative, pMMR/MSS Advanced Gastric Cancer
ClinicalTrials.gov study NCT06992024. IPD Sharing: Not stated. Countries: 1. Publications: 5.
Study to Determine Safety and Dose of NJH395 in Non-breast HER2+ Advanced Cancer
ClinicalTrials.gov study NCT03696771. IPD Sharing: NO. Countries: 4. Publications: 1.
A Safety and Efficacy Study of ZW25 (Zanidatamab) Plus Combination Chemotherapy in HER2-expressing Gastrointestinal Cancers, Including Gastroesophageal Adenocarcinoma, Biliary Tract Cancer, and Colore
ClinicalTrials.gov study NCT03929666. IPD Sharing: NO. Countries: 4. Publications: 1.
HER2 Expression Detection and Radionuclide Therapy in Breast Cancer Using 99mTc/188Re Labeled Single Domain Antibody
ClinicalTrials.gov study NCT04674722. IPD Sharing: Not stated. Countries: 1. Publications: 4.
A Study of the Efficacy and Safety of Trastuzumab Emtansine (Trastuzumab-MCC-DM1) vs. Trastuzumab (Herceptin®) and Docetaxel (Taxotere®) in Patients With Metastatic HER2-positive Breast Cancer Who Hav
ClinicalTrials.gov study NCT00679341. IPD Sharing: Not stated. Countries: 0. Publications: 2.
Neoadjuvant Endocrine Therapy Versus Chemotherapy in Premenopausal Patients With ER+ & HER2- Breast Cancer
ClinicalTrials.gov study NCT02535221. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Chemotherapy Plus Monoclonal Antibody Therapy in Treating Women With Stage II or Stage IIIA Breast Cancer That Overexpresses HER2
ClinicalTrials.gov study NCT00003992. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Ipilimumab, Nivolumab, and Talimogene Laherparepvec Before Surgery in Treating Participants With Localized, Triple-Negative or Estrogen Receptor Positive, HER2 Negative Breast Cancer-deleted
ClinicalTrials.gov study NCT04185311. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Evaluate Safety, Tolerability and Pharmacokinetics of HLX22 in Patients With Advanced Solid Tumors Overexpressing HER2
ClinicalTrials.gov study NCT03916094. IPD Sharing: NO. Countries: 1. Publications: 1.
Letrozole and Metronomic Capecitabine in ER-positive HER2 Negative Advanced Breast Cancer (B-001 Study)
ClinicalTrials.gov study NCT04571437. IPD Sharing: NO. Countries: 1. Publications: 1.
Disitamab Vedotin (RC48) in Hormone Receptor Positive, HER2-low Metastatic Breast Cancer (the Rosy Trial)
ClinicalTrials.gov study NCT05904964. IPD Sharing: NO. Countries: 1. Publications: 9.
Anti-HER2 Therapy in Patients of HER2 Positive Metastatic Carcinoma of Digestive System
ClinicalTrials.gov study NCT03185988. IPD Sharing: NO. Countries: 1. Publications: 1.
Trastuzumab Based Therapy in HER2 Positive AGC
ClinicalTrials.gov study NCT03024450. IPD Sharing: NO. Countries: 1. Publications: 8.
Adherence to Aromatase Inhibitors ± Abemaciclib Treatment in Patients With Early-stage HER2-negative Breast Cancer
ClinicalTrials.gov study NCT06650423. IPD Sharing: UNDECIDED. Countries: 0. Publications: 23.
Safety and Efficacy of Toripalimab in HER2- Metastatic Breast Cancer Patients Treated With Metronomic Vinorelbine
ClinicalTrials.gov study NCT04389073. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Pyrotinib in Combination With Fulvestrant in Patients With HER2 Positive,HR-Positive Metastatic Breast Cancer
ClinicalTrials.gov study NCT04034589. IPD Sharing: NO. Countries: 1. Publications: 7.
Monoclonal Antibody Plus Chemotherapy in Treating Patients With Advanced Colorectal Cancer That Overexpresses HER2
ClinicalTrials.gov study NCT00003995. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study of AC Followed by a Combination of Paclitaxel Plus Trastuzumab or Lapatinib or Both Given Before Surgery to Patients With Operable HER2 Positive Invasive Breast Cancer
ClinicalTrials.gov study NCT00486668. IPD Sharing: Not stated. Countries: 3. Publications: 2.
Study of Pembrolizumab in Metastatic HER2-negative Breast Cancer Patients With APOBEC3B Mutation
ClinicalTrials.gov study NCT03989089. IPD Sharing: Not stated. Countries: 2. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.